Fluoro[(2S)-3-{[(9Z)-hexadec-9-enoyl]oxy}-2-methoxypropyl]propanedioic acid

ID: ALA4648374

PubChem CID: 156020178

Max Phase: Preclinical

Molecular Formula: C23H39FO7

Molecular Weight: 446.56

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CC(F)(C(=O)O)C(=O)O)OC

Standard InChI:  InChI=1S/C23H39FO7/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(25)31-18-19(30-2)17-23(24,21(26)27)22(28)29/h8-9,19H,3-7,10-18H2,1-2H3,(H,26,27)(H,28,29)/b9-8-/t19-/m0/s1

Standard InChI Key:  LVBNGOSRIOTEDK-QWUACUGRSA-N

Molfile:  

 
     RDKit          2D

 31 30  0  0  0  0  0  0  0  0999 V2000
   26.2304  -17.1678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9416  -16.7539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6541  -17.1656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3653  -16.7517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0778  -17.1633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7889  -16.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5014  -17.1611    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.2085  -16.7473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9210  -17.1589    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.2072  -15.9260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.5213  -16.7616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8150  -17.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8178  -17.9898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1115  -18.4008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4024  -17.9946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6960  -18.4056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9870  -17.9994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2806  -18.4104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6288  -16.7505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3364  -17.1593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0442  -16.7509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7518  -17.1597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4596  -16.7513    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1672  -17.1601    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.4598  -15.9341    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.7516  -17.9769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0437  -18.3853    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.4592  -18.3857    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.7471  -16.3397    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   33.3362  -17.9765    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.6283  -18.3849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  1 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
  9 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 22 26  1  0
 26 27  1  0
 26 28  2  0
 22 29  1  0
 20 30  1  6
 30 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4648374

    ---

Associated Targets(Human)

LPAR1 Tchem Lysophosphatidic acid receptor Edg-2 (779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.56Molecular Weight (Monoisotopic): 446.2680AlogP: 5.07#Rotatable Bonds: 20
Polar Surface Area: 110.13Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 2.39CX Basic pKa: CX LogP: 5.86CX LogD: 0.38
Aromatic Rings: Heavy Atoms: 31QED Weighted: 0.12Np Likeness Score: 0.76

References

1. González-Gil I, Zian D, Vázquez-Villa H, Hernández-Torres G, Martínez RF, Khiar-Fernández N, Rivera R, Kihara Y, Devesa I, Mathivanan S, Del Valle CR, Zambrana-Infantes E, Puigdomenech M, Cincilla G, Sanchez-Martinez M, Rodríguez de Fonseca F, Ferrer-Montiel AV, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S..  (2020)  A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration.,  63  (5): [PMID:31790581] [10.1021/acs.jmedchem.9b01287]

Source